Meridian Clinical Research

Meridian Clinical Research partners with pharmaceutical and biotechnology companies to research new drugs, medical devices, and diagnostics that could improve human health and wellbeing. Founded in 1999, Meridian is headquartered at its dedicated research center in Omaha, NE, and conducts Phase 1-4 studies at investigative sites across North America. Meridian supports research across numerous therapeutic areas and specializes in high-volume vaccine trials.

Meridian offers:

Rapid data turnaround, easy communication, and fast start-up.

Broad therapeutic expertise and support for special patient populations.

Call centers to expedite patient recruitment, retention, and follow-up.

Access to an expansive site network and patient database (Platinum Research Network member).

Meridian maintains proprietary patient databases and leverages research and physician practice databases to provide direct access to potential study participants. Meridian is also the largest member of the Platinum Research Network, which provides access to more than 47 million patients globally. Due to the strategic footprint of this site network, Meridian studies often serve as an additional care option for patients currently seeking treatment for conditions.

Geographically and demographically diverse, Meridian’s network enables prompt access to a viable study infrastructure.